期刊文献+

456例泌尿生殖道支原体感染耐药性分析 被引量:2

Drug resistance analysis of 456 cases of mycoplasma infection in urogenital tract
下载PDF
导出
摘要 目的 分析泌尿生殖道主要感染菌及耐药性.方法 泌尿生殖道支原体感染患者456例,进行支原体培养和药敏试验.结果 主要感染菌是Uu、Mh和Uu+Mh,女性明显高于男性(78.08%vs 47.31%,P<0.05);最敏感药物为强力霉素、交沙霉素、美满霉素和四环素,敏感度为82%~99%.单纯Uu感染对环丙沙星(74.46%)、氧氟沙星(59.74%)、司帕沙星(48.49%)耐药性高;单纯感染Mh菌株对红霉素(95.46%)、阿奇霉素(90.91%)、克拉霉素和罗红霉素(86.36%)耐药性高;Uu+Mh感染对罗红霉素(97.22%)、红霉素(94.44%)及阿奇霉素和氧氟沙星(91.67%)耐药性高.结论 应根据病原菌种类和药敏试验选择抗生素. Objective To study the main infection genitourinary and the drug resistance of mycoplasma infection in uro- genital tract. Methods Selected 456 patients with mycoplasma infection in urogenital culture identification and drug sensitivity test. Results The main pathogenic bacteria of female infection (78.08%), significantly higher than the 97 male cases of infection tract, and tested with mycoplasma was Uu, Mh and Uu+Mh.196 cases (47.31%), the difference was sta- tistically significant (P〈0.05). The most sensitive drug were doxycycline, josamycin, minocycline and tetracycline.The sensitivity was between 82%~99%.The simple Uu infection to high antibiotic resistance was ciprofloxacin (74.46%), ofloxacin (59.74%) and sparfloxacin (48.49%). The simple Mh infection to high antibiotic resistance was erythromycin (95.46%), azithromycin (90.91% ), clarithromycin and roxithromycin (86.36%). Uu+Mh mixed infection to high antibiotic resistance was roxithromycin (97.22%), erythromycin (94.44%) and azithromycin and ofloxacin (91.67%). Conclusion We should choose antibiotics according to the infection of Mycoplasma species and drug sensitive test.
出处 《中国现代医生》 2014年第9期74-76,共3页 China Modern Doctor
关键词 泌尿生殖道 支原体感染 耐药性 Urogenital tract Mycoplasma infection Tolerance
  • 相关文献

参考文献11

二级参考文献51

共引文献26

同被引文献25

  • 1Patrick RM,Ellen JB,James HJ,et al.Manual of Clinical Microbiology[M].8th.Washington:American Society for Microbiology,2003:1060-1061. 被引量:1
  • 2Parker S,Lipman J,Koulenti D,et al.What is the relevance of Fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review[J].Int J Antimicrob Agents,2013,42 (4):289-293. 被引量:1
  • 3Giamarellou H,Poulakou G.Multidrug-resistant Gramnegative infections:what are the treatment options?[J].Drugs,2009,69(14):1879-1901. 被引量:1
  • 4Martin K,Florian S,Agnes A,et al.Fosfomycin susceptibility in carbapenem-resistant enterobacteriaceae from Germany[J].J Clin Microbiol,2014,52(6):1893-1897. 被引量:1
  • 5Delgado-Valverde M,Sojo-Dorado J,Pascual A,et al.Clinical management of infections caused by multidrugresistant Enterobacteriaceae[J].Ther Adv Infect Dis,2013,1 (2):49-69. 被引量:1
  • 6Perdig(a)o-Neto LV,Oliveira MS,Rizek CF,et al.Susceptibility of multiresistant Gram-negative bacteria to Fosfomycin and performance of different susceptibility testing methods[J].Antimicrob Agents Chemother,2014,58 (3):1763-1767. 被引量:1
  • 7Lu CL,Liu CY,Huang YT,et al.Antimicrobial susceptibilities of commonly encountered bacterial isolates to Fosfomycin determined by agar dilution and disk diffusion methods[J].Antimicrobial Agents And Hemotherapy,2011,55 (9):4295-4301. 被引量:1
  • 8Falagas ME,Kastoris AC,Karageorgopoulos DE,et al.Fosfomycin for the treatment of infections caused by multidrug-resistantnon-fermenting Gram-negative bacilli:a systematic review of microbiological.animal and clinical studies[J].Int J Antimicrob,2009,34(2):111-120. 被引量:1
  • 9Falagas ME,Roussos N.Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance:a review of microbiological,animal and clinical studies[J].Expert Opin Investig Drugs,2009,18 (7):921-944. 被引量:1
  • 10Drosos EK,Vivi M,Leonidas ST,et al.Emergence of resistance to Fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia:report of three cas es[J].J Antimicrob Chemother,2012,67(11):2777-2779. 被引量:1

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部